Free Trial

ZyVersa Therapeutics (ZVSA) News Today

ZyVersa Therapeutics logo
$1.14 -0.01 (-0.43%)
(As of 11:50 AM ET)
ZyVersa Therapeutics Reports Q3 Progress and Outlook
ZyVersa Therapeutics reports Q3 EPS ($2.43) vs ($30.18) last year
ZyVersa Therapeutics’ Shareholder Approvals and Director Elections
ZyVersa highlights review article on inflammasome-induced inflammation
What's Going On With ZyVersa Stock?
Why Is ZyVersa Therapeutics (ZVSA) Stock Up 37% Today?
Get ZyVersa Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZVSA and its competitors with MarketBeat's FREE daily newsletter.

Breaking News: Tesla headed to $500… (Ad)

That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.

So to claim your free digital copy today, simply follow this link and enter your email address. 

ZVSA Media Mentions By Week

ZVSA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ZVSA
News Sentiment

0.21

0.47

Average
Medical
News Sentiment

ZVSA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ZVSA Articles
This Week

3

1

ZVSA Articles
Average Week

Get ZyVersa Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZVSA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ZVSA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners